Barclay Phillips
Direttore/Membro del Consiglio presso IMMUNIC, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Barclay Phillips
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNIC, INC. | Direttore/Membro del Consiglio | 19/11/2019 | - |
| Independent Dir/Board Member | 19/11/2019 | - | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Direttore/Membro del Consiglio | - | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Direttore operativo | 04/08/2020 | - |
| Direttore Finanziario/CFO | 04/08/2020 | - |
Storia della carriera di Barclay Phillips
Precedenti posizioni note di Barclay Phillips
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Direttore Finanziario/CFO | 08/11/2017 | 10/05/2019 |
| NOVAVAX, INC. | Direttore Finanziario/CFO | 24/06/2013 | 10/11/2017 |
| Treasurer | 24/06/2013 | 10/11/2017 | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Direttore Finanziario/CFO | 01/12/2000 | 29/07/2009 |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Direttore degli Investimenti | 01/11/1999 | 30/09/2008 |
| Membro del Comitato di Investimento | 01/11/1999 | 30/09/2008 | |
| Analista di Private Equity | 01/11/1999 | 30/09/2008 | |
| Investitore di Private Equity | 01/11/1999 | 30/09/2008 | |
| Corporate Officer/Principal | 01/11/1999 | 30/09/2008 | |
Vector Fund Management LP
 Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Corporate Officer/Principal | 01/01/1999 | 01/08/2008 |
| CancerVax Corp. | Direttore/Membro del Consiglio | 01/12/2000 | 09/05/2006 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Barclay Phillips
| University of Colorado Boulder | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 16 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 6 |
| Director/Board Member | 4 |
| Director of Finance/CFO | 4 |
Settori
| Finance | 8 |
| Health Technology | 8 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
| CancerVax Corp. | Commercial Services |
Invesco Advisers, Inc.
 Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers, Inc. is a SEC-registered investment advisor headquartered in Atlanta, Georgia. They are a subsidiary of Invesco Group Services, Inc., ultimately held by Invesco Ltd. (NYSE: IVZ). The firm was founded in 1986 and previously known as Invesco Institutional NA, Inc. until April 2010 when Invesco Ltd. consolidated the businesses of their US investment advisors (Invesco AIM Advisors, Inc., Invesco AIM Capital Management, Inc., Invesco AIM Private Asset Management, Inc. and Invesco Global Asset Management NA, Inc.) under the name Invesco Advisers, Inc. They provide discretionary and non-discretionary investment advisory services to individuals, institutional and high net-worth clients through separate accounts, wrap fee programs and US registered investment companies and other Commingled Funds. | Finance |
| PaineWebber, Inc. | Finance |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Apjohn Ventures LLC
 Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
INVESCO Funds Group, Inc.
 INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO. | Finance |
| Shearson Lehman Hutton, Inc. | Finance |
Vector Fund Management LP
Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
- Borsa valori
- Insiders
- Barclay Phillips
- Esperienza